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Abstract: Seventeen free-ranging moose {Alces alces) (2 adult males, 13 adult females and 2 female calves) were immobili-
zed with a combination of medetomidine hydochloride (MED) and ketamine hydrochloride (KET) in early autumn 
(August-September). Drugs were administrated with plastic projectile syringes fired from a dart gun, either from a car 
or by approaching the animals on foot. MED at 30 mg/adult and 15 mg/calf in combination with KET at 400 mg/adult 
and 200 mg/calf induced complete immobilization with sternal or lateral recumbency and loss of the corneal reflex in 
all individuals. The mean ± SD time from darting to when the animals were found was 18.3 ± 8.7 min for adults and 
the mean distance covered by these animals between darting and recumbency was 320 + 200 m. No side effects of cli-
nical significance were detected and registration of the rectal temperature (38.8 ± 0.5°C), heart rate (44 ± 7 beats/min), 
respiratory rate (31 ±20 breaths/min) and relative arterial oxygen saturation (89 ± 3 %, n=8) during immobilization in 
adults showed that these physiological parameters were within the safe ranges established for moose. Blood samples 
from adults were analyzed for 17 haematological and 33 serum biochemical constituents and the results were compared 
to corresponding values found in moose immobilized with etorphine (ETO). Although the lower levels (p<0.05) found 
for haematocrit, red blood cells, haemoglobin and Cortisol in the MED-KET group may indicate a difference in the 
stress response, the low muscle enzyme levels in both groups show that these immobilizing drugs and capture methods 
induce very little physical stress in moose. A hyperglycaemic response was found in MED-KET treated animals. 
Atipamezole hydrochloride (ATI) rapidly remobilized all animals and the time elapsing from ATI administration to 
standing was 3-9 ± 1.8 min after i.v./s.c. treatment (n=7) and 6.9 ± 3.4 min after i.m./s.c. injection (n=8). No side 
effects were detected after reversal. In conclusion, medetomidine-ketamine and atipamezole can be recommended for 
reversible immobilization of free-ranging moose in early autumn. 
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Introduction 
Etorphine has been the drug of choice for immobili-
zation of free-ranging moose (Alces alces), both in 
Scandinavia (Sandegren et al., 1987) and in North 
America (Franzmann & Lance, 1988). Carfentanil, a 
more potent opioid than etorphine, has been used 
for moose capture in U.S.A. and Canada since 1984, 
mainly because a concentrated solution of etorphine 
was not commercially available (Franzmann & 
Lance, 1988). However, both agents are extremely 
toxic for humans (Haigh & Hudson, 1993) and the-
re is a great need for a non-opioid alternative. 
Free-ranging moose have been immobilized 
with xylazine (Doherty & Tweedie, 1989; Miller & 
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Litvaitis, 1992; Mikalsen & Arnemo, 1993) and 
xylazine-ketamine (Schwab et al, 1984; Garner & 
Addison, 1994). However, these agents are less sui-
table for this purpose because of the large drug 
volumes needed and their variable effects. 
In recent years, medetomidine, a more potent 
alpha2-adrenoceptor agonist than xylazine, has been 
used in combination with ketamine for immobiliza-
tion of various captive, non-domestic mammals 
(Jalanka, 1993)- Atipamezole, a potent and selective 
alpha2-adrenoceptor antagonist, is available for 
rapid and permanent reversal of the medetomidine-
unduced effects (Jalanka, 1993). Jalanka & Roeken 
(1990) reported the use of medetomidine-ketamine 
in captive moose, but complete and reliable immo-
bilization was not achieved with the doses tested. In 
other cervids like Svalbard reindeer (Rangifer taran-
dus platyrhynchus) and red deer (Cervus elaphus) med-
etomidine-ketamine was found to be effective for 
chemical capture of free-living individuals (Tyler et 
al, 1990; Arnemo et al, 1994). 
The aim of the present study was to evaluate 
medetomidine-ketamine and atipamezole for rever-
sible immobilization of free-ranging moose in early 
autumn. 
Material and methods 
Data were collected in early autumn (August-
September) 1992-1993. Seventeen free-ranging 
moose including 2 males and 13 females aged more 
than 24 months and 2 female calves (approximately 
3 months old) were immobilized with a combinati-
on of medetomidine hydrochloride (MED) and 
ketamine hydrochloride (KET) as part of a study on 
moose ecology in Aust-Agder County, Norway. 
Drugs were administered with plastic projectile 
syringes fired from a dart gun (DAN-INJECT8, J. 
Lund-J0rgensen, DK-7080 B0rkop, Denmark), eit-
her from a car or by approaching the animals on 
foot. The doses for adults were 30 mg MED 
(Medetomidine hydrochloride 30 mg/ml, Orion 
Corporation Animal Health Division, FIN-20101 
Turku, Finland) and 400 mg KET (Ketamine 
hydrochloride 200 mg/ml reconstituted from dry 
powder, Parke, Davis & Co. Ltd., Usk Road, 
Pontypool, Gwent, NP4 OYH, United Kingdom), 
and for calves 15 mg MED and 200 mg KET. To 
avoid disturbance during the induction phase, the 
standard procedure was to wait for 10 min after dar-
ting before tracking the animals with dogs 
(Norwegian elkhounds). The time from darting to 
when the animal was found («induction time») was 
recorded and the distance covered by the animal 
after darting (walking distance) was estimated. 
Immobilized animals were monitored (body posture 
and regularity and amplitude of respiration) to avo-
id clinical complications such as bloat and regurgi-
tation and to detect signs of respiratory depression. 
The corneal reflex was used to assess the depth of 
anaesthesia in immobilized animals. The following 
physiological parameters were recorded 20—50 min 
after darting: rectal temperature (°C), heart rate 
(beats/min) and respiratiory rate (breaths/min). 
Relative oxygen saturation (%) was recorded in 
eight animals using pulse oximetry (NELLCOR" 
N-10, Nellcor Inc., Pleasanton, California 94588, 
USA) with the sensor applied to the tongue. Adult 
moose were tagged with a plastic eartag in both ears 
and fitted with radio collars (Televilt International 
AB, S-71700 Storå, Sweden). Calves received a plas-
tic eartag and an eartag radiotransmitter (Televilt 
International AB). 
Blood samples for haematology and serum bio-
chemistry were drawn from the jugular vein of 
adult animals 20-50 min after darting, using 10 ml 
evacuated tubes and 0.9 x 40 mm needles 
(Venoject®, Terumo Europe NV, 3001 Leuven, 
Belgium). Serum was separated by centrifugation of 
the plain samples within 6 hours of collection. The 
serum and EDTA samples were stored in a refrigera-
tor overnight and sent by post to the Central 
Laboratory for Clinical Chemistry, Norwegian 
College of Veterinary Medicine, PO Box 8146 
Dep., 0033 Oslo, Norway, where they were analy-
zed for selceted parameters by standard procedures. 
For comparison, blood samples were collected from 
nine free-ranging moose (4 males and 1 female aged 
12—16 months and 4 males aged more than 24 
months) immobilized with etorphine in summer or 
early autumn (June-September) 1992-1994 in 
Nordland County, Norway (J. M. Arnemo, unpub-
lished data). The animals were captured using the 
same equipment and methods as in the main part of 
this study. 
Atipamezole hydrochloride (ATI) (Antisedan8 5 
mg/ml, Orion Corportaion Animal Health 
Division) at five times the dose of MED (i.e. 150 
mg ATI/adult and 75 mg ATI/calf) was administe-
red to all animals for reversal of immobilization. 
The time from darting to injection of ATI (time to 
reversal) was recorded. The ATI dose was divided 
and given half i.v. and half s.c. in seven adults and 
one calf and half i.m. and half s.c. in eight adults 
and one calf. The times from ATI administration to 
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Table 1. Summary of drug doses, induction times, walking distances, physiological parameters, times to reversal and 
head-up and on-feet times in adult, free-ranging moose immobilized with medetomidine-ketamine and remo-
bilized with atipamezole in early autumn (Augst-September) 1992-1993 in Aust-Agder County, Norway. 
n Mean ± SD Range 
Medetomidine hydrochloride (mg/animal) 15 30 — 
Ketamine hydrochloride (mg/animal) 15 400 -
Induction time3 (min) 15 18.3 ± 8.7 1.3-35.0 
Walking distance'3 (m) 15 320 ± 200 10-750 
Rectal temperature (°C) 15 38.8 ± 0.5 38.2-39-8 
Heart rate (beats/min) 15 44 ± 7 30-60 
Respiratiory rate (breaths/min) 15 31 ± 20 10-68 
Relative oxygen saturation (%) 8 89 ± 3 85-92 
Atipamezole hydrochloride (mg/animal) 15 150 -
Time to reversal0 (min) 15 49 ± 10 32-64 
Head-up timê  (min) i.v./s.c. 7 1.9 ± 0.8* 1.3-3.3 
i.m./s.c. 8 4.1 ± 2.1 1.0-7.5 
On-feet timee (min) i.v./s.c. 7 3.9 ± 1.8 1.7-6.3 
i.m./s.c. 8 6.9 ± 3.4 1.5-10.5 
a Time from darting to when the animal was found. 
k Distance covered by the animal between darting and recumbency. 
c Time from darting to administration of the antagonist. 
d>e Times from administration of the antagonist to head-lifting and standing, respectively. 
* Significant difference (p<0.0.5) between routes of administration. 
when the animal lifted its head (head-up time) and 
to when it was standing (on-feet time) were recor-
ded. 
The ambient temperature during the trials ran-
ged from 12 to 20°C. The animals were periodically 
tracked by radiotelemetry for up to two years after 
treatment. 
Statistical calculations were performed with 
NCSS® (Number Cruncher Statistical System, 
Kaysville, Utah 84037, USA). The two-sample t-
test was used to compare the head-up and on-feet 
times after i.v./s.c. and i.m./s.c. administration of 
ATI, respectively, and to compare haematological 
and serum biochemical values from moose treated 
with medetomidine-ketamine and etorphine, 
respectively. Logarithmic transformation was used 
for parameters that were not normally distributed 
(white blood cell and neutrophil counts, aspartate 
aminotransferase and creatinine). P-values <0.05 
were considered to be significant. 
Results 
Data on drug doses, induction times, physiological 
paramteres, times to reversal and head-up and on-
feet times for adult animals are summarized in 
Table 1. Medetomidine-ketamine induced complete 
immobilization with loss of the corneal reflex in 
both adults and calves. Due to the tracking proce-
dure, the actual induction times are not known for 
all animals. However, three animals were observed 
going down, one adult female after 1.33 min and 
two calves close to their immobilized dams after 4.0 
and 5.0 min, respectively. Most animals were found 
in sternal recumbency, they offered no resistance to 
handling and could easily be turned over to their 
sides. Examination of the calves revealed rectal tem-
peratures of 39-9 and 40.0°C, heart rates of 58 and 
68 beats/min and respiratory rates of 28 and 32 bre-
aths/min. 
Clinical complications were not detected during 
immobilization. However, one adult female develo-
ped periodic apnoea 40 min after darting and was 
immediately given ATI i.v./s.c. without further eva-
luation of the severity of respiratory depression. 
This individual had twin calves and was in poor 
body condition. 
Haematological and serum biochemical values 
are summarized in Tables 2 and 3, respectively. 
Immobilization was rapidly reversed by admi-
nistration of ATI (Table 1). Head-up and on-feet 
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Table 2. Haematological values in chemically immobilized free-ranging moose (Alces alces): a comparison between mede-
tomidine-ketamine and etorphine. Data are given as mean + SD. 
Parameter (unit) Medetomidine-ketamine Etorphine 
(n = 15) (n = 9) 
Haematocrit (L/L) 0.37 ± 0.02 * 0.47 ± 0.04 
Red blood cells (xl012/L) 5.62 ± 0.46 * 7.09 ± 0.46 
Haemoglobin (g/L) 129 ±7 * 166 ± 18 
Mean corpuscular volume (fL) 65.3 ± 3.8 66.5 ± 4.0 
Mean cell haemoglobin (pg) 23.1 ± 1.6 23.2 ± 1.6 
Mean corpuscular haemoglobin concentration (g/L) 353 ± 10 350 ± 17 
Red cell distribution width (%) 16.3 ± 0.7 15.9 ± 0.7 
Haemoglobin distribution width (g/L) 19.7 ± 2.0 19.7 ± 2.2 
Platelets (xlO /̂L) 202 ± 85 234 ± 77 
Mean platelet volume (fL) 5.5 ± 1.0 5.3 ± 0.6 
White blood cells (xlO /̂L) 4.28 ± 1.21 4.33 ± 1.88 
Neutrophils (xlO /̂L) 1.96 ± 0.87 2.48 ± 1.60 
(n = 8) 
Lymphocytes (xlO /̂L) 1.30 ± 0.43 1.32 ± 0.31 
(n = 8) 
Monocytes (xlO /̂L) 0.12 ± 0.06 0.16 ± 0.07 
(n = 8) 
Eosinophils (xl09/L) 0.80 ± 0.37 * 0.23 ± 0.18 
(n = 8) 
Basophils (xl09/L) 0.38 ± 0.29 0.25 ± 0.13 
(n = 13) (n = 8) 
Large unstained cells (xl09/L) 0.10 ± 0.04 0.13 ± 0.06 
(n = 8) 
* Significant difference (p<0.05) between groups. 
times for the calves were 0.83 and 1.33 min, respec-
tively, after i.m./s.c. injection, and 5.0 and 8.0 min, 
respectively, after i.m./s.c. administration. Reversals 
were calm and without side effects. All animals got 
up at the first attempt and were able to walk or run 
in a coordinated manner, although a slight stiffness 
of gait was seen in a few individuals. All animals 
urinated shortly after they were on-feet. 
All treated animals recovered completely and no 
drug-related complications or behavioural changes 
were detected during the follow-up radiotracking 
study. In spring 1993, all females (n=4) with intact 
transmitters produced single calves. In spring 1994, 
only two out of seven females produced calves. 
Three females died from natural causes: one cow 
probably had dystocia and was found dead 9 months 
after tagging; one cow fell into a ditch 10 months 
after tagging and, although rescued, died within 24 
hours; one cow drowned in a lake 17 months after 
tagging. One of the males lost the transmitter one 
month after tagging and was shot during the tegu-
lar hunt shortly afterwards. Both calves lost their 
transmitters during their first winter. One female 
was short during the regular hunt two months after 
tagging, while three females lost their transmitters 
9, 10 and 15 months after tagging, respectively. 
Discussion 
The medetomidine-ketamine combination was very 
efficient for the capture of free-ranging moose. All 
animals became completely immobilized after one 
injection and no side effects of clinical significance 
were detected. Absence. of the corneal reflex in 
immobilized animals indicates that the depth of 
anaesthesia may be suitable for surgical intervention 
(Booth, 1988). 
Rapid induction is essential in the chemical 
capture of wildlife so that the animals can be found, 
handled and monitored within a short time after 
drug administration. Due to the tracking procedu-
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Table 3. Serum biochemical values in chemically immobilized free-ranging moose (Akes akes): a comparison between 
medetomidine-ketamine and etorphine. Data are given as mean ± SD. 
Parameter (unit) Medetomidine-ketamine 
(n = 15) 
Etorphine 
(n = 9) 
Protein, total (g/L) 67.4 ± 3.1 69.9 ± 3.2 
Albumin (g/L) 37.1 ± 3.7 * 43.6 ± 5.1 
Globulin, total (g/L) 30.3 ± 5.3 26.4 ± 3.8 
°c-globulin (g/L) 10.7 ± 1.4 * 8.7 ± 1.8 
ß-globulin (g/L) 7.0 ± 1.2 6.8 ± 0.8 
Ü-globulin (g/L) 12.6 ± 3.5 10.8 ± 2.6 
Albuminrglobulin ratio 1.28 ± 0.34 * 1.69 ± 0.38 
Urea (mmol/L) 5.5 ± 2.4 5.4 ± 1.7 
Creatinine (umol/L) 147 ± 29 155 ± 56 
Uric acid (pmol/L) 18 ± 4 20 ± 9 
Total bilirubin (pmol/L) 2 ± 1 3 ± 1 
(n = 8) 
Cholesterol (mmol/L) 1.7 ± 0.2 1.7 ± 0.4 
Triglycerides (mmol/L) 0.3 ± 0.1 0.3 ± 0.2 
Free fatty acids (mmol/L) 0.2 ± 0.2 * 1.0 ± 0.3 
ß-Hydroxybutyric acid (mmol/L) 0.3 ± 0.1 0.3 ± 0.1 
Glucose (mmol/L) 8.4 ± 1.0 6.2 ± 0.9 
Cortisol (nmol/L) 168 ± 76 533 ± 113 
(n = 7) (n = 5) 
Aspartate aminotransferase (U/L) 99 ± 26 100 ± 27 
Alanine aminotransferase (U/L) 32 ± 7 * 20 ± 6 
Alkaline phosphatase (U/L) 251 ± 130 407 ± 276 
Creatine kinase (U/L) 113 ± 30 99 ± 23 
Lactate dehydrogenase (U/L) 835 ± 130 959 ± 202 
Ü-Glutamyltransferase (U/L) 16 ± 6 13 + 4 
Glutamate dehydrogenase (U/L) 4 ± 4 * 1 ± 1 
(n = 14) 
Amylase (U/L) 90 ± 23 * 118 ± 26 
Lipase (U/L) 27 ± 20 47 ± 30 
Inorganic phostphate (mmol/L) 0.8 ± 0.4 * 1.9 ± 0.6 
Calcium (mmol/L) 2.5 ± 0.1 * 2.6 ± 0.2 
Magnesium (mmol/L) 1.20 ± 0.17 * 1.40 ± 0.20 
Sodium (mmol/L) 143 ± 3 143 ± 5 
Potassium (mmol/L) 4.2 ± 0.5 * 4.9 ± 0.5 
Chloride (mmol/L) 101 ± 2 99 ± 3 
Iron (pmol/L) 21 ± 6 28 + 7 
* Significant difference (p<0.05) between groups. 
re, the actual induction time is unknown for most of 
the animals in the present study. However, the fact 
that three individuals were seen going down and 
that all the other animals were completely immobi-
lized when found, strongly indicates that the actual 
times from darting to recumbency were probably 
much shorter than the recorded «induction» times 
(x=18.3 min). 
Garner & Addison (1994) reported that the 
mean time from the first injection to recumbency 
for 22 free-ranging female moose immobilized with 
xylazine-ketamine in spring was 18.4 min and that 
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all animals required multiple injections. Although 
these authors concluded that xylazine-ketamine was 
suitable for the immobilization and capture of moo-
se, my data clearly indicate that medetomidine-
ketamine is a better combination. 
There is no doubt that etorphine is an extremely 
safe drug for the immobilization of moose in winter. 
Approximately 970 captures of free-ranging indivi-
duals with etorphine have been carried out in 
Norway and only two drug-related fatalitites have 
occurred (M. Heim, pers. comm. 1995). However, a 
major side effect of etorphine is hyperthermia and 
Franzmann (1982) discouraged immobilization of 
moose at ambient temperatures above 10°C. 
Reports on the use of xylazine in August -
September (Miller & Litvaitis, 1992) and of xylazi-
ne-ketamine in May — June (Garner & Addison, 
1994) did not include information about the body 
temperature or other physiological parameters in 
immobilized moose, or the ambient temperature 
during the studies. 
Although the normal body temperature in 
unmedicated free-ranging moose is not known, 
Franzmann et al. (1984) considered the safe range 
and the critical value for the rectal temperature in 
moose to be 38.4 - 38.9 and 40.2°C, respectively. 
In the present study, immobilization with medeto-
midine-ketamine did not produce critical hyper-
thermia in any of the animals, even on sunny days 
with an ambient temperature of up to 20°C. 
Franzmann et al. (1984) reported the safe ranges 
and critical values for the heart and respiratory rates 
to be 70-91 and 103 beats/min, and 13-40 and 40 
breaths/min, respectively. The bradycardia seen in 
all animals in the present study is probably a mede-
tomidine-mediated effect (Jalanka, 1993). Al-
though tachypnoea was recorded in a few individu-
als, a high relative arterial oxygen saturation was 
registered in all animals, indicating that ventilation 
is adequate during immobilization with medetomi-
din-ketamine. 
The diuretic effect of alpha-2 adrenoceptor ago-
nists is well established (Maze & Tranquilli, 1991; 
Jalanka, 1993) and explains why all the animals in 
the present study passed copious amounts of urine 
shortly after reversal. 
Reference ranges for some blood values in moose 
have been reported by Franzmann & LeResche 
(1978). However, results from their study should be 
interpreted with caution, because pooled data from 
animals immobilized with different drugs and from 
animals killed during hunting were used. 
According to Wesson et al. (1979), it is undesirable 
to combine and compare blood samples obtained by 
different methods such as shooting, immobilizing 
drugs or physical restraint. 
Several blood stress parameters were significant-
ly lower in animals treated with medetomidine-
ketamine than in animals treated with etorphine. 
An increase in the haematocrit, red blood cell 
count, and hameoglobin and Cortisol concentrations 
is part of the animal's normal stress-response 
(Franzmann et al., 1975; Arnemo et al., 1994) and 
may indicate that etorphine-immobilization is more 
stressful to the animal. The hyperglycaemia found 
in animals treated with medetomidine-ketamine is 
a well-knwon alph -̂adrenoceptor-mediated effect 
(Jalanka, 1993). Low levels of aspartate aminotrans-
ferase, creatine kinase and lactate dehydrogenase 
indicate that physical stress associated with capture 
was minimal in both groups of animals, and that 
muscle damage did not occur (Spraker, 1993). 
Significant differences in some of the other blo-
od parameters are probably unrelated to the drug 
effects: nutritional factors and body condition may 
influence the serum levels of proteins, minerals and 
metabolites (Franzmann & LeResche, 1978), while 
the difference in eosinophilic cell counts may indi-
cate different parasitic burdens (Jain, 1986). 
Although Franzmann & LeResche (1978) did not 
find any sex differences in blood values during the 
summer/autumn season, the skewed sex distributi-
on between animals treated with medetomidine-
ketamine (mostly females) and those treated with 
etorphine (mostly males) may have influenced som 
of the results in the present study. 
It is highly desirable that an effective reversal 
agent is available to shorten the recovery in captu-
red wildlife, especially in ruminants which may 
develop life-threatening bloat and regurgitation 
while recumbent. In the present study, atipamezole 
rapidly remobilized the moose, both after i.v./s.c. 
and i.m./s.c. administration, and side effects were 
not seen. Because i.v. administration of atipamezole 
may cause ataxic recovery (Jalanka, 1993), I suggest 
that the i.m./s.c. route should be used on a routine 
basis. 
Garner & Addison (1994) used yohimbine to 
reverse xylazine-ketamine immobilization in moose. 
Although yohimbine was given partly intravenous-
ly, the recovery was slow, the mean time from injec-
tion to standing being 22.8. min. The authors did 
not include information on side effects such as rese-
dation. Yohimbine is a less potent and selective 
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alpha2-adrenoceptor antagonist than atipamezole, 
especially in ruminants (Arnemo & Søli, 1993; 
Jalanka & Roeken, 1990), and may cause heavy 
resedation after the initial arousal effect (Jalanka & 
Roeken, 1990). 
In conclusion, the present study showed mede-
tomidine-ketamine and atipamezole to be excellent 
drugs for the reversible immobilization of free-
ranging moose under the described circumstances. 
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